Dr. Al-Juhaishi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 NE 10th St
Oklahoma City, OK 73104Phone+1 405-271-4022Fax+1 405-271-3020
Education & Training
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2014 - 2017
- Weill Cornell Medical College in QatarClass of 2014
Certifications & Licensure
- OK State Medical License 2021 - 2025
- VA State Medical License 2014 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma.Gulrayz Ahmed, Mehdi Hamadani, Taha Al-Juhaishi
Expert Opinion on Biological Therapy. 2025-01-16 - Trends and disparities in cardiovascular disease-related mortality among adults with myeloproliferative neoplasms in USA.Siddharth Agarwal, Usama Qamar, Muhammad Shahzeb Khan, Taha Al-Juhaishi, Abdul Rafeh Naqash
European Heart Journal Open. 2025-01-01 - Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes.Olivia Davis, Carmen Lessani, Rana Kasht, Andrew Cohoon, Sami Ibrahimi
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: